Search research articles
Contact Us
Filters
Showing results (681-690 of 709) with videos related to
Page
of 71
Sort By:
JHEP Reports : Innovation in Hepatology
|
December 9, 2025
The efficacy of atezolizumab plus bevacizumab for advanced hepatocellular carcinoma in relation to tumor-infiltrating lymphocytes
Hiroaki Kanzaki, Takamasa Ishino, Sadahisa Ogasawara, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
August 23, 2023
Multicenter phase II study of capecitabine plus oxaliplatin in older patients with advanced gastric cancer: the Tokyo Cooperative Oncology Group (TCOG) GI-1601 study
Ryohei Kawabata, Keisho Chin, Daisuke Takahari, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology
|
November 24, 2021
Exploring microsatellite instability in patients with advanced hepatocellular carcinoma and its tumor microenvironment
Shohei Mukai, Hiroaki Kanzaki, Sadahisa Ogasawara, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 5, 2023
A Prospective Study Exploring the Safety and Efficacy of Lenvatinib for Patients with Advanced Hepatocellular Carcinoma and High Tumor Burden: The LAUNCH Study
Kazufumi Kobayashi, Sadahisa Ogasawara, Susumu Maruta, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology
|
February 8, 2021
Propofol <i>versus</i> midazolam for sedation during radiofrequency ablation in patients with hepatocellular carcinoma
Naoya Kanogawa, Sadahisa Ogasawara, Yoshihiko Ooka, et al.
BMC Gastroenterology
|
March 11, 2023
Use of ramucirumab for various treatment lines in real-world practice of patients with advanced hepatocellular carcinoma
Naoya Kanogawa, Sadahisa Ogasawara, Susumu Maruta, et al.
Journal of the American College of Cardiology
|
November 12, 2021
Risk-Benefit of 1-Year DAPT After DES Implantation in Patients Stratified by Bleeding and Ischemic Risk
Tullio Palmerini, Antonio Giulio Bruno, Björn Redfors, et al.
Scientific Reports
|
November 2, 2021
EZH1/2 inhibition augments the anti-tumor effects of sorafenib in hepatocellular carcinoma
Yuko Kusakabe, Tetsuhiro Chiba, Motohiko Oshima, et al.
Investigational New Drugs
|
June 8, 2019
Sequential therapy with sorafenib and regorafenib for advanced hepatocellular carcinoma: a multicenter retrospective study in Japan
Sadahisa Ogasawara, Yoshihiko Ooka, Norio Itokawa, et al.
Anticancer Research
|
February 28, 2023
Successful Identification of a Novel Therapeutic Compound for Hepatocellular Carcinoma Through Screening of ADAM9 Inhibitors
Keita Ogawa, Tetsuhiro Chiba, Masato Nakamura, et al.
Page
of 71
Search research articles
Search
Showing results (681-690 of 709) with videos related to
Sort By:
Page
of 71
JHEP Reports : Innovation in Hepatology
|
December 9, 2025
The efficacy of atezolizumab plus bevacizumab for advanced hepatocellular carcinoma in relation to tumor-infiltrating lymphocytes
Hiroaki Kanzaki, Takamasa Ishino, Sadahisa Ogasawara, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
August 23, 2023
Multicenter phase II study of capecitabine plus oxaliplatin in older patients with advanced gastric cancer: the Tokyo Cooperative Oncology Group (TCOG) GI-1601 study
Ryohei Kawabata, Keisho Chin, Daisuke Takahari, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology
|
November 24, 2021
Exploring microsatellite instability in patients with advanced hepatocellular carcinoma and its tumor microenvironment
Shohei Mukai, Hiroaki Kanzaki, Sadahisa Ogasawara, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 5, 2023
A Prospective Study Exploring the Safety and Efficacy of Lenvatinib for Patients with Advanced Hepatocellular Carcinoma and High Tumor Burden: The LAUNCH Study
Kazufumi Kobayashi, Sadahisa Ogasawara, Susumu Maruta, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology
|
February 8, 2021
Propofol <i>versus</i> midazolam for sedation during radiofrequency ablation in patients with hepatocellular carcinoma
Naoya Kanogawa, Sadahisa Ogasawara, Yoshihiko Ooka, et al.
BMC Gastroenterology
|
March 11, 2023
Use of ramucirumab for various treatment lines in real-world practice of patients with advanced hepatocellular carcinoma
Naoya Kanogawa, Sadahisa Ogasawara, Susumu Maruta, et al.
Journal of the American College of Cardiology
|
November 12, 2021
Risk-Benefit of 1-Year DAPT After DES Implantation in Patients Stratified by Bleeding and Ischemic Risk
Tullio Palmerini, Antonio Giulio Bruno, Björn Redfors, et al.
Scientific Reports
|
November 2, 2021
EZH1/2 inhibition augments the anti-tumor effects of sorafenib in hepatocellular carcinoma
Yuko Kusakabe, Tetsuhiro Chiba, Motohiko Oshima, et al.
Investigational New Drugs
|
June 8, 2019
Sequential therapy with sorafenib and regorafenib for advanced hepatocellular carcinoma: a multicenter retrospective study in Japan
Sadahisa Ogasawara, Yoshihiko Ooka, Norio Itokawa, et al.
Anticancer Research
|
February 28, 2023
Successful Identification of a Novel Therapeutic Compound for Hepatocellular Carcinoma Through Screening of ADAM9 Inhibitors
Keita Ogawa, Tetsuhiro Chiba, Masato Nakamura, et al.
Page
of 71